When Anna Pesce was visiting her children in Wagener, SC, in November 2014, the then-85-year-old Orangeburg, NY, native almost collapsed trying to climb a set of stairs.
When Erin and Marianne Krupa decided they wanted to start a family five years ago, they moved from North Carolina to New Jersey in search of a less conservative environment.
As communities nationwide battle a growing opioid and heroin use epidemic, researchers and public health officials are scrambling to identify how abuse may begin.
Despite living amid a culture obsessed with selfies and Kim Kardashian’s weight, for the first time in recent history, more women report feeling confident about their bodies, a new research analysis suggests.
A 6-year-old boy with leukemia saw his young dreams come true when he was able to join the California Highway Patrol for a day, even dressing in uniform and helping pull over speedy drivers.
When relationship researchers gathered recently for their big international conference, one presentation drew a lot of attention because it offered an answer to a question often asked but rarely examined: Can sexual fantasies improve your relationship?
PROVIDENCE, R.I. — Marine veteran Joyce Ralph sometimes stays at home in Massachusetts instead of going for a bike ride or doing other things she likes to do.
There is a large market for unauthorized online sales of secondhand continuous positive airway pressure (CPAP) devices, which treat obstructive sleep apnea, according to a new study.
Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by widely used biotech medicines, according to data from a mid-stage trial.
Many websites marketing unproven stem cell therapies directly to consumers are popping up even in developed nations where laws have been passed to protect patients from false medical advertising, a new study suggests.
Japan's Eisai Co said on Tuesday the U.S. Food and Drug Administration had confirmed that there was sufficient data to start Phase III studies of a drug it is co-developing to treat early Alzheimer's disease.